欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/1205/003
药品名称Idarrubicina Accord
活性成分
    • Idarubicin hydrochloride 20.0 mg/20ml
剂型Solution for injection
上市许可持有人Accord Healthcare Limited
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Denmark (DK)
      Idarubicinhydrochlorid "Accord"
    • Belgium (BE)
      Idarubicin Accord 20 mg/20 ml solution injectable
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Idarubicin Accord 20 mg/20 ml Injektionslösung
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Estonia (EE)
      IDARUBICIN ACCORD
    • Cyprus (CY)
      IDARUBICIN ACCORD 20MG/20ML SOL FOR INJ
    • Czechia (CZ)
      Idarubicin Accord 20mg/20ml, injekční roztok
    • Romania (RO)
      Idarubicina Accord 20 mg/20 ml soluție injectabilă
    • Slovenia (SI)
许可日期2016/11/23
最近更新日期2024/11/25
药物ATC编码
    • L01DB06 idarubicin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase